Renewable Energy and Power (OTC: RBNW), a LED lighting and power solutions company, has started a marketing campaign for sales of its patent-pending germicidal LED lighting fixture.
The company, which focuses on making the Green Energy market cost competitive with fossil fuels through innovation in solar, wind-power and LED lighting, made the announcement around the middle of July and commenced the campaign after completing hundreds of hours of burn-in testing.
Also announced was a second provisional patent that had been submitted for slightly different designs of the unit. These different designs will allow for the unit to be placed in virtually every type of LED ceiling panel lighting including new fixtures and existing lighting fixtures.
According to the company’s press release, each LED ceiling panel light processes 5.3 cubic feet per minute of ambient air, moving it through a HEPA filter to remove particulate matter and passing it before an ultraviolet germicidal irradiation (UVGI) light to destroy pathogens.
The company’s LED Sterilization Panel Light is said to offer a more effective and lower cost alternative to any other method of air purification, including that provided in central air circulation systems.
According to clinical studies, air must be passed multiple times through UVGI lights in order for it to be truly effectively clean. In Renewable Energy and Power’s UVGI unit in ceiling panel lights, the ambient air will constantly be re-exposed to the sterilization process over and over again, which promises for more effective cleaning.
CEO Donald MacIntyre stated, “The lights performed up to our expectations in both sterilization effectiveness and the quality of long-term performance. With the minimal additional cost of including this UVGI sterilization with the lower cost and more effective benefits of LED lighting, we believe the company’s germicidal LED ceiling panels will have wide appeal.”
The company’s initial market focus is on the healthcare sector that includes 300,000 facilities. These facilities include doctors, dental, and pharma. The company also targets other sectors such as hospitality, institutional, and consumer.
A TechSci Report has recently noted that the demand for innovative air purification is expected to pass $29 billion by 2021. The global demand for consumer air treatment systems is expected to grow at a double-digit annual pace to more than $10 billion in 2019, acording to Freedonia Group.